Phase2 study of perioperative chemotherapy with SOX and operation for Stage3 colorectal cancer(SOS3)
Phase 2
- Conditions
- Resectable Colorectal Cancer
- Registration Number
- JPRN-UMIN000006790
- Lead Sponsor
- Fukuoka Tumor Research(FUTURE)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Prior severe drug allergy 2.Nursing or pregnant females,or females or mailes with female partners who are planning pregnancy 3.Presence of active infection 4.Serious complications(Such as ileus, uncontrolled diabetes and so on) 5.Inadequate for study enrollment by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method